Saturday, October 03, 2015 4:01:27 PM
http://www.chicagotribune.com/bluesky/originals/ct-fda-nsaids-otc-drugs-bsi-20150714-story.html
Will FDA warnings prompt innovation in over-the-counter painkillers?
"Americans spent $3.9 billion in 2014 on internal analgesics — over-the-counter pain relievers and fever reducers — according to the Consumer Healthcare Products Association. Then there are opioids, powerful painkillers such as Oxycodone and Codeine."
"Rech added that while drugs such as Tylenol and ibuprofen are effective painkillers, the new concern about side effects may incentivize innovation in developing and improving painkillers."
Never buy/sell a stock on my recommendation alone. Always do your own DD and be aware of the risks!
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM